Brazil Pharmaceuticals & Healthcare Report Q2 2016 - New Market Research Report

From: Fast Market Research, Inc.
Published: Sun Jan 24 2016

Brazil will continue to be the most important market for multinational pharmaceutical companies in Latin America, d espit e growing financial tensions, increasing pricing pressure and generic competition. Headline Expenditure Projections

Pharmaceuticals: BRL65.8bn (USD19.8bn) in 2015 to BRL69.8bn (USD18.4bn) in 2016; +6.1% in local currency terms and -7.0% in US dollar terms. Forecast in has stayed the same as in Q 116 .

Healthcare: BRL509.9bn (USD216.7bn) in 2015 to BRL601.1bn (USD158.2bn) in 2016; +8.3% in local currency terms and -5.0% in US dollar terms . Forecast in local currency has been revised downward from Q 116 .

Risk/Reward Index

Brazil scores 61.9 in BMI's Pharmaceutical and Healthcare Risk/Reward Index (RRI), making it the fourth-most attractive pharmaceutical market in the Americas this quarter. We highlight that Brazil will continue to be the most important market for multinationals in Latin America. Its position has been very well reflected in this quarter's RRI scores, primarily a result of the country's consistent economic growth and the government's commitment to promoting local industry.

Full Report Details at

The Brazil Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Brazil Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Brazil pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's pharmaceutical and healthcare market forecasts for Brazil, to test other views - a key input for successful budgeting and strategic business planning in the Brazilian pharmaceutical and healthcare market.
* Target business opportunities and risks in the Brazilian pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Brazil.
* Assess the activities, strategy and market position of your competitors using our company profiles (including SWOTs, KPIs and latest activity) and competitive landscape tables.


BMI Industry View

An at-a-glance perspective on the latest regulatory developments, key forecast indicators and major corporate developments, covering the prescription, OTC and generics markets. The pharmaceuticals and healthcare SWOT outlines strategic factors that affect the basic assumptions underpinning BMI’s forecast analysis, and taken together with BMI’s political, economic and business environment SWOTs, it gives a complete overview of market climate.

BMI Industry Forecast Scenario

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- China Pharmaceuticals & Healthcare Report Q2 2016
- France Pharmaceuticals & Healthcare Report Q1 2016
- Saudi Arabia Pharmaceuticals & Healthcare Report Q1 2016
- Kenya Pharmaceuticals & Healthcare Report Q1 2016
- Thailand Pharmaceuticals & Healthcare Report Q1 2016

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »